Not Tagged
Not Tagged
['multiple myeloma']
great to hear tim somervaille summarising inobrodib early clinical data at ash, treating relapsed refractory multiple myeloma . #ash22 
Biotech CEO, Dir, Chair; CellCentric, Cyted, F2G, VaxEquity. Morningside Ventures. Prev. JIC, BBSRC, BIA.